Established in 2022, Reinforce3D emerged from a collaboration between Eurecat, Catalonia’s leading research and technology organization, BKIF, a deep science fund managed by BeAble Capital, and Marc ...
The FDA approved the first-ever generic form of a GLP-1 receptor agonist specifically indicated for weight loss, Teva Pharmaceuticals announced Thursday. The generic form of liraglutide (Saxenda) is ...